Visceral metastasesDisease1 paperHuman trial1LatestAdvances in Therapy·25 OctEverolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysisRandomised trial in peoplemTOR inhibitorsPaper
Advances in Therapy·25 OctEverolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysisRandomised trial in peoplemTOR inhibitorsPaper